FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of subvariantsCNBC • 01/27/23
AstraZeneca's preventive COVID therapy no longer effective against current variantsMarket Watch • 01/26/23
ENHERTU® Approved in the EU as the First HER2 Directed Therapy for Patients with HER2 Low Metastatic Breast CancerBusiness Wire • 01/26/23
Thermo Fisher Scientific Partners with AstraZeneca to Develop Solid Tissue and Blood-Based Companion Diagnostic Test for TagrissoBusiness Wire • 01/24/23
AIM ImmunoTech shares rise on news of pancreatic cancer research partnership with AstraZeneca and Erasmus Medical CenterProactive Investors • 01/17/23
AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion DealInvestors Business Daily • 01/09/23
AstraZeneca's COVID drug Evusheld unlikely to neutralize newest variant, FDA saysMarket Watch • 01/06/23
GSK, AstraZeneca: Will the two UK drugs giants ride the US$74bn pharma wave or will they be left beached?Proactive Investors • 01/06/23